This webinar, focusing on New Nanoscale Platforms for Drug Delivery, provides detailed, complementary examples of the role that nanoporous silicon, in either nanoparticle or nanoneedle form, can address in terms of existing issues in treating human disease. Dr. Cunin, in her presentation, clearly demonstrates the utility of porphyrin-modified porous silicon particles in two-photon-assisted therapies that tackle aggressive cancers such as those in young children. In his presentation, Dr. Chiappini focuses on one-dimensional nanoneedles of silicon that can be applied to gene therapies, cell-based therapies, and spatial omics.

The future appears to be quite promising with the possible use of these types of nanomaterials in therapeutic applications.

The webinar was hosted on Zoom and required prior registration to attend. The full recording can be accessed below. In order to learn about future webinars, you can sign up for our newsletter by clicking “Subscribe” at the top of this page.